Stockscreener 앱 받기
1.17
1.68%
-0.02
시간 외 거래:
1.21
0.04
+3.42%
전일 마감가:
$1.19
열려 있는:
$1.1898
하루 거래량:
35,592
Relative Volume:
0.16
시가총액:
$20.37M
수익:
$52.58M
순이익/손실:
$-3.28M
주가수익비율:
-6.0716
EPS:
-0.1927
순현금흐름:
$-2.53M
1주 성능:
+3.54%
1개월 성능:
+15.84%
6개월 성능:
+18.06%
1년 성능:
+20.16%
1일 변동 폭
$1.17
$1.195
1주일 범위
$1.11
$1.195
52주 변동 폭
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
명칭
Iridex Corp
전화
(650) 940-4700
주소
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.17 | 20.54M | 52.58M | -3.28M | -2.53M | -0.1927 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-11-03 | 재개 | ROTH Capital | Buy |
| 2016-12-21 | 개시 | ROTH Capital | Buy |
| 2016-01-26 | 개시 | Singular Research | Buy |
| 2007-01-03 | 개시 | First Albany | Buy |
Iridex Corp 주식(IRIX)의 최신 뉴스
Insider Buying: Romeo Dizon Acquires Additional Shares of IRIDEX Corp (IRIX) - GuruFocus
Iridex CFO Romeo Dizon buys $1,110 in company stock - Investing.com UK
Iridex CFO Romeo Dizon buys $1,110 in company stock By Investing.com - Investing.com India
IRIDEX (IRIX) CFO Romeo Dizon adds 975 common shares in open-market buy - Stock Titan
Iridex CFO Romeo Dizon buys $1,909 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $1,909 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 1,675 shares in open-market stock purchase - Stock Titan
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference - The Manila Times
Iridex CFO Romeo Dizon buys $2,688 in company stock By Investing.com - Investing.com Australia
Iridex CFO Romeo Dizon buys $2,688 in company stock - Investing.com
IRIDEX (IRIX) CFO Romeo Dizon adds 2,400 shares in open-market buy - Stock Titan
Iridex CFO Dizon purchases $2,899 of common stock By Investing.com - Investing.com India
Iridex CFO Dizon purchases $2,899 of common stock - Investing.com UK
IRIDEX Corp (IRIX) CFO adds 2,521 shares in open-market stock purchase - Stock Titan
IRIDEX Corp stock (US4627191006): Laser eye-care specialist after recent earnings update - AD HOC NEWS
Iridex CFO Romeo Dizon buys $2,808 in company stock By Investing.com - Investing.com Nigeria
Iridex CFO Romeo Dizon buys $2,808 in company stock - Investing.com
CFO of IRIDEX (NASDAQ: IRIX) purchases 2,400 company shares - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock By Investing.com - Investing.com Australia
IRIDEX (IRIX) CEO Patrick Mercer delivers shares to cover tax obligations - Stock Titan
Iridex CFO Romeo Dizon buys $5,004 in company stock - Investing.com
IRIDEX Corp (IRIX) CFO adds 5,004 common shares in open-market buy - Stock Titan
IRIDEX Trades Around $1 Following Holiday, Eye-Care Firm Faces Next Challenges - Bez Kabli
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth - Yahoo Finance
IRIDEX Corporation (IRIX) Q1 2026 Earnings Surge: EPS $-0.03 vs $-0.07 ForecastGross Profit Margin - Newser
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX) - The Globe and Mail
IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
IRIDEX Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Iridex Beats Profit Forecasts on Cost Cuts Amidst Revenue Dip - BriefGlance
Earnings call transcript: IRIDEX Q1 2026 posts EPS beat despite revenue miss - Investing.com
Iridex Q1 2026 Earnings Call: Complete Transcript - Benzinga
IRIDEX earnings beat by $0.02, revenue fell short of estimates - Investing.com
IRIDEX Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Is IRIDEX (IRIX) a Value Trap After Q1 2026? EPS -$0.03 Beats (e - GuruFocus
Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens - ChartMill
Iridex posts narrower-than-feared Q1 loss driven by cost cuts; Shares up 4% - Investing.com South Africa
Iridex Reports Q1 2026: Revenue $11.8M, Gross Profit $4.7M, Net Loss $0.5M - TradingView
IRIDEX CORP 1Q 2026: Revenue $11.8M, EPS $(0.03) — 10-Q Summary - TradingView
IRIDEX (NASDAQ: IRIX) narrows quarterly loss as margins tighten - Stock Titan
Iridex (NASDAQ: IRIX) Q1 loss narrows as 2026 outlook reaffirmed - Stock Titan
Iridex: Q1 Earnings Snapshot - marketscreener.com
Iridex Reports First Quarter 2026 Financial Results - Yahoo Finance
IRIDEX Corp stock (US4627191006): eye-care specialist draws attention after FDA clearance and strate - AD HOC NEWS
IRIDEX Corp expected to post a loss of 7 cents a shareEarnings Preview - TradingView
IRIDEX Corp stock (US4627191006): Ophthalmology device maker with recent market activity - AD HOC NEWS
Iridex Corp (IRIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Iridex Corp 주식 (IRIX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '26 |
Buy |
1.14 |
1,675 |
1,909 |
135,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 08 '26 |
Buy |
1.12 |
2,400 |
2,688 |
133,325 |
| Dizon Romeo R | Chief Financial Officer |
Jun 05 '26 |
Buy |
1.15 |
2,521 |
2,899 |
130,925 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '26 |
Buy |
1.17 |
2,400 |
2,808 |
128,404 |
| Dizon Romeo R | Chief Financial Officer |
May 26 '26 |
Buy |
1.00 |
5,004 |
5,004 |
126,004 |
| Dizon Romeo R | Chief Financial Officer |
Mar 06 '26 |
Buy |
1.26 |
1,110 |
1,399 |
121,000 |
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
2.43%
자본화:
|
볼륨(24시간):